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Snml'nary 
Keratinocyte growth factor (KGF) is a member of the fibroblast growth factor (FGF) family 
(hence the alternative designation FGF-7). It is produced by stromal calls, but acts as a mitogen 
for epithelial calls. We examined the effects of topically applied KGF on healing of wounds in 
a porcine model. In partial-thickness  wounds, KGF stimulated  the rate of reepithelialization 
(p <0.0002),  associated with a thickening of the epidermis (p <0.0001). Epidermis from KGF- 
treated full-thickness wound sites was significantly thicker (0.31  :t: 0.22 ram) compared with 
mirror image control sites (0.18  :t: 0.12 mm) (p <0.0001).  Moreover, the majority (77%) of 
KGF-treated wounds exhibited epidermis with a deep fete ridge pattern as compared with control 
sites. These effects were observed as early as 14 d and persisted for at least 4 wk. KGF treatment 
also increased the number of serrated basal calls associated with increased deposition of collagen 
fibers in the superficial dermis adjacent to the acanthotic epidermis. Electron microscopy revealed 
better developed hemidesmosomes associated  with thicker bundles of tonofilaments in the serrated 
cells. The pattern of epidermal thickening observed in KGF-treated wounds resembled psoriasis. 
Psoriasis is a disease  associated with epidermal thickening, parakeratosis as well as hyperproliferation 
that extends beyond the basal layer. In striking contrast to psoriasis, KGF-treated wounds exhibited 
normal orthokeratotic maturation, and proliferation was localized to the basal cells. Our present 
findings have significant implications concerning the role of KGF as a paracrine modulator of 
epidermal proliferation and differentiation. 
D 
uring the past two decades, the importance of growth 
factors in wound healing has become increasingly ap- 
parent as a cascade of growth factor-mediated events must 
be temporally orchestrated to achieve proper wound healing 
(1, 2). Healing is a complex and protracted process involving 
an initial inflammatory phase, a period of cellular prolifera- 
tion and extracellular matrix (ECM) 1 synthesis, and even- 
tually a phase of remodeling of the matrix (3). These events 
are  both  independently and  coordinately  influenced  by 
numerous growth factors and/or cytokines secreted  by inflam- 
matory cells, as well as by other cells residing within, or at 
the edges of the wound bed. The rate at which wounds heal, 
1 Abbreviations used in this paper: ANOVA, analysis of variance; BMZ, 
basement membrane  zone; ECM, =tracellular  matrix; EGF, epidermal 
growth factor; EM, electron  microscopy;  FGF, fibrnblast  growth factor; 
H&E, hematoxylin  and eosin; KGF, keratinocyte  growth factor. 
and the degree of "healing" achieved, are likely influenced 
by growth factor presentation and cellular response within 
the wound bed (4, 5). Kecent studies have implicated a wide 
variety of polypeptide growth factors as critical elements in 
angiogenesis, fibroplasia, cdlular proliferation, and reepithe- 
lialization of wounds. Epidermal growth factor (EGF) and/or 
TGF-ot influence migration and proliferation of epidermal 
keratinocytes, which represent critical elements in the essen- 
tial reepithelialization  process of wound healing (6-10). TGF-~/ 
induces  fibroplasia,  including  synthesis  of collagen  and 
fibronectin, both of which are associated with the wound 
matrix (11-19). Phtelet-derived growth factor (PDGF) fosters 
angiogenesis and granulation tissue formation in the wound 
(20-25).  Recent studies in animal models and humans have 
indicated that application of exogenous growth factors to 
wounds accelerates healing (7-11, 16, 20-25, 26-29). 
Members of the fibroblast growth factor (FGF) family have 
been implicated in the wound-healing process (23, 24, 30). 
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to injury (23, 24). Acidic (a)FGF, basic (b)FGF, FGF-5, and 
FGF-7 (also known as keratinocyte growth factor [KGF]) are 
expressed in normal, unwounded skin, and their expression 
is upregnlated early after full thickness injury (31). Of par- 
ticular interest, however,  are recent observations that KGF 
(FGF-7) expression  was increased  to a much greater extent 
than the other FGFs (>100-fold above baseline).  Moreover, 
its expression  remained elevated through the first  7 d after 
injury, implicating KGF as a potentially important physio- 
logic mediator of wound repair (31). 
KGF is a unique member of the FGF family (32,  33),  in 
that studies thus far indicate that it operates solely as a para- 
crine growth factor, exhibiting epithelial cell-specific targeting 
(for a review see reference 34).  Dermal fibroblasts  produce 
KGF but do not express its receptor and do not respond to 
exogenous KGF (34).  In contrast, epidermal keratinocytes 
do not synthesize KGF, but instead express the KGF receptor. 
Keratinocytes were stimulated to proliferate (35) and migrate 
(35a) in response  to exogenous KGF. KGF was as potent as 
EGF in its ability to induce mitogenesis in cultured keratino- 
cytes (35). A distinguishing feature of KGF from EGF, how- 
ever, was its ability to facilitate expression of differentiation- 
related markers in human keratinocytes exposed to 1.0 mM 
calcium (35). In addition, unlike its better characterized family 
member bFGF, which does not contain a signal peptide, KGF 
has a signal sequence  and is secreted  from cells (34). 
The epithelial-specific  targeting of KGF (in vitro), com- 
bined with its demonstrated expression during wound healing, 
suggest that KGF may play a pivotal role in early wound- 
healing processes. The present studies were designed to assess 
whether exogenous KGF could modulate the wound-healing 
response in porcine skin. The results of these studies suggest 
that KGF increases the rate of reepithelialization of partial- 
thickness wounds. In full-thickness wounds KGF treatment 
elicits:  (a) epidermal thickening; (b) serration of basal cells; 
(c) better developed  tonofilaments and hemidesmosomes in 
basal keratinocytes; and (d) increased abundance of collagen 
in the papiUary dermis. 
Materials and Methods 
Source of KGE  Recombinant KGF protein was expressed in 
bacteria (36) using the T7 expression system (37). After sonication 
and clarification of the bacterial lysate, KGF was purified by se- 
quential chromatography on heparin-Sepharose (Pharmacia, Pis- 
caraway, NJ) and Mono-S (Pharmacia) resins. The homogeneity 
of this preparation was confirmed by silver-stain analysis  of protein 
electrophoresed in SDS-polyacrylamide  gels and the yield deter- 
mined by amino acid analysis. The recombinant protein demon- 
strated  mitogenic  activity for  mouse, human,  and  swine ker- 
atinocytes. 
Animal Use.  All experiments were carried out with prior ap- 
proval of the Cornell University Medical College Institutional An- 
imal Care and Use Committee. A total of 11 domestic Yorkshire 
pigs (50-80 pounds) were used for these studies. 
Creation of  Partial-thickness Wounds.  Animals were anesthetized 
before surgery and wounds were created using a dermatome set 
at a 0.015 inches in depth (Padget, a division of Kansas City As- 
semblage Co., Kansas  City, MO). A series of shallow, mirror image, 
partial-thickness wounds (-1  x  2 in) were created on the lateral 
paravertebral skin of each pig in a cephalad-caudad orientation. 
Mirror image wounds were chosen so that each  KGF-treated  wound 
had its own vehicle-control site that would be at an anatomically 
similar position with regard to the location (i.e., cephalad  or caudad) 
on the pig. This is important since skin thickness, wound contrac- 
tion, and healing can vary depending upon the site from which 
the skin is taken. Use of mirror image wounds allowed compar- 
ison of equivalent skin for each set of control and KGF-treated 
wounds. 
Two animals were used for these studies. Nine pairs of wounds 
were created on the first pig, whereas four pairs of wounds were 
created on the second animal. After creation of the wounds, the 
left or fight side of each mirror image wound pair was randomly 
chosen to receive  either KGF (1/~g/wound in 50/~1 PBS) or vehicle 
(50 #1 PBS alone). All wounds were photographed at a fixed dis- 
tance (12 in) from the wound bed with a sterile ruler next to the 
wound for size standardization. A ring flash was used to ensure 
uniform lighting. Each wound was then dressed  with polyurethane 
dressing (Op-Site; Smith and Nephew Med. Ltd., Hull, UK) and 
covered with burn dressing (Intersorb; Sherwood Med., St. Louis, 
MO) and Spandage (Medi-Tech International, Brooklyn, NY). 
On days  3-4 after surgery, histologic analysis  of all wounds was 
performed. This time period was chosen since such shallow  wounds 
routinely heal within '~6 d. Histologic examination of the wounds 
allowed us to assess whether the healing process and/or the mor- 
phologic appearance of the healed (or healing) skin was altered by 
treatment with KGF. Elliptical biopsies were made through the 
center of each wound, including normal margins of unwounded 
skin,  5-/zm sections were stained with hematoxylin and eosin 
(H&E). Three criteria, namely,  reepithelialization,  epidermal thick- 
ness, and epidermal maturity, were used to quantitate the effects 
of KGF on partial-thickness wound healing. 
The percent of reepithelialization across each wound site was 
measured  by microscopy  using a reticle within the microscope  eye- 
piece to measure the proportion of each wound that was covered 
by epidermis in comparison to the entire wound length. 
Epidermal thickness was defined as the distance (in millimeters) 
from the top of the granular layer (if present) to the bottom of 
the basal layer. If a granular layer was not present, then the top- 
most layer of keratinocytes was used as the upper boundary for 
such quantitation. Light microscopy using an ocular reticle was 
again used for these measurements. Approximately 30 individual 
measurements of epidermal thickness were made along the wound 
site for each histologic section and the mean thickness quantitated. 
Finally,  the presence  or absence  of a mature granular layer  and/or 
a stratum comeum were considered  criteria for a maturing epidermis. 
All wound evaluations were carried out with the investigator 
blinded to the treatment group. After decoding of the data, each 
parameter (i.e., reepithelialization,  epidermal thickness, and epider- 
mal maturity) from an individual KGF-treated wound was com- 
pared with its mirror image control site. 
Creation of Full-thickness Wounds.  Nine separate animals were 
used for studies of KGF effects. Before creation of full-thickness 
wounds, a series of grids (8  x  8 cm subdivided into 1-cm  2 boxes) 
were stamped and tattooed in mirror image array on the dorsal 
surface of each animal as above. Full-thickness wounds (4 cm  2) 
were created by surgical excision of the four center boxes of each 
grid to the trapezius or latissimus dorsi fascia. The left or right 
side of each mirror image wound pair was then treated with either 
KGF (1 #g/wound in 50 #1 PBS) or vehicle (50/~1 PBS alone) (see 
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the wounds dressed (as described above). On day 3 after surgery, 
KGF (or vehicle) was reapplied to wounds as before. All wound 
dressings were changed on day 7 and at weekly intervals thereafter. 
At each dressing change, all wounds were photographed at a stan- 
dard distance (12 in). Wounds (KGF and mirror image controls) 
were evaluated at weekly intervals up to 4 wk after wounding using 
the parameters described below. 
Wound contraction was quantitated by computerized morpho- 
metric image analysis of the photographic slides taken of  each wound 
(JAVA Video Analysis  Software System; Jandel Scientific,  Corte 
Madera, CA). Standardized photography, combined with the pres- 
ence of a ruler within each photograph allowed accurate quantita- 
tion of wound size by electronically tracing the grid that outlined 
each wound (38). Data analysis was carried out with the investi- 
gator blinded to the treatment group of the wounds. Wound con- 
traction of each KGF-treated site was then compared with its mirror 
image control site as a function of time after surgery. 
The histologic appearance of the healing skin during the course 
of each experiment was determined by examination of H&E-stained 
5-#m sections as described above. Separate histologic sections also 
were stained with Masson Trichrome to evaluate the extent of col- 
lagen  bundle  formation  in  KGF-  and  control-treated wounds. 
Epidermal thickness was defined as described above and quanti- 
tared for each wound. 
The kinetic profile of keratinocyte proliferation during wound 
healing was quantitated by standard immunohistochemical tech- 
niques utilizing an anti-Ki-67 antibody (MIB-1; Amac, Inc., West- 
brook, ME) (39). Biopsies from control and KGF-treated sites ob- 
tained 1, 2, and 3 wk after wounding were reacted with Ki-67. 
Normal unwounded pig skin and human skin from a psoriatic pa- 
tient served  as controls. 
Expression of the basement membrane component laminin was 
determined using anti-laminin Abs (clone 2E10) obtained from Dr. 
Eva EngvaU (La Jolla Cancer Research Institute, La Jolla, CA) and 
reacted with air-fixed  cryostat sections of skin. 
Finally, ultrastructural features of the control and KGF-treated 
sites were assessed by electron microscopy (EM) on tissue that was 
fixed  in  cacodylate-buffered 2%  glutaraldehyde,  post-fixed  in 
OsO4,  and  embedded  in  Epon  812  (EM  Sciences;  Fort 
Washington, PA) after progressive dehydration. Silver sections were 
cut on a microtome (Ultracut E; Reichert-Jung, Vienna, Austria). 
Sections were stained with uranyl acetate and lead citrate before 
viewing on an electron microscope (model 100 cx; JEOL U.S.A. 
Inc., Peabody,  MA). 
Statistical Evaluation.  For partial-thickness wounds, analysis of 
variance (ANOVA) for a crossover trial with replications was used 
to determine if a difference existed between the two treatments 
(PBS and KGF) with regard to percent reepithelialization of the 
wounds and epidermal thickness of the healed skin. This design 
took into account the different number of paired sites within an 
animal (otherwise called replications), as well as the fact that each 
animal received each of two treatments (hence the term crossover); 
p <0.01 was considered statistically  significant. 
For full-thickness wounds, ANOVA for a crossover trial was again 
employed to determine the difference in thickness between PBS- 
and KGF-treated mirror image wounds; p <0.01 was considered 
statistically significant (see above for design considerations). 
For wound contraction studies, paired Student's t tests were per- 
formed at each of six time points (days 0, 3, 7,  14, 21, and 28) 
with each replication or site per animal treated as a separate record 
to determine whether there was a difference between the two treat- 
ments (KGF and PBS). The paired Student's t test was used be- 
cause each animal received both treatments, is  animals were paired 
across treatments;/<0.01 was considered statistically  significant. 
Results 
The Effects of KGF on Reepithetialization  of Partial-thickness 
Wounds.  KGF was applied to dermatome-derived superficial, 
partial-thickness  wounds  in  two  animals.  The  degree  of 
reepithelialization, thickness of the epidermis, and degree of 
epidermal maturation were assessed in control and KGF-treated 
wounds on the third day after treatment (Table 1). KGF in- 
creased the extent of reepithelialization in partial-thickness 
wounds compared with mirror image control wounds (82.5 
_+  21.8 and 51.7  _+  22.5% reepithdialization for KGF and 
control wounds, respectively; p <0.0002).  H&E-stained sec- 
tions  of a  representative  set  of wounds  showed  complete 
epithelialization of the KGF-treated site (Fig.  1 B). By con- 
trast, incomplete epithelial coverage of the mirror image con- 
trol site was  observed (Fig.  1 A).  Healed skin from KGF- 
treated wounds was also significantly thicker than healed skin 
from mirror image control wounds  (0.07  _  0.02 vs 0.05 
+  0.02 mm thickness for KGF- and PBS-treated wounds, 
respectively; iv <0.0001). 
The percent epithelialization and epidermal thickness of 
Table  1.  Reepithelialization and Epidermal Thickness of Partial-thickness Wounds Treated with KGF or PBS 
Keepithelialization 
(Mean  %  _+  SD) 
Expt.  Pairs  of wounds  PBS  KGF  ~ 
Epidermal thickness 
(mm  _  SD) 
PBS  KGF  b 
1  9  41.1  _+  12.7  78.9  _+  24.2" 
2  4  83.3  _+  11.6  93.3  _+  5.8 
Total 2  13  51.7  _+  22.5  82.5  _+  21.8 
0.06  _+ 0.02 
0.03  _+ 0.02 
0.05  _+ 0.02 
0.08  _+ 0.02 
0.06  _+ 0.01 
0.07  _+ 0.02 
Statistical analysis based upon ANOVA  for a crossover trial design (see Materials and Methods). 
" Significance =  p <0.0002 for percent reepithelialization of PBS- vs. KGF-treated wounds. 
* Significance = p <0.0001 for epidermal thickness of PBS- vs KGF-treated wounds. 
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healing in swine. (/1 and B) The effects of KGF 
on  partial-thickness wounds.  Mirror  image 
wounds received either PBS (.4) or KGF (B). 
A representative  set of  partial-thickness  wounds 
revealed  that KGF-treated  wounds (B) (day  3 
after  surgery) exhibited  more extensive 
reepithellall,ation  compared  with mirror  image 
control rites (A). (A) (e) Edge of epidmnis; 
(c) neutrophil-contalni,g crust.  (C-F)  The 
efl~,s Of  KGF on fu]l-thi&n~ wounds. Evalu- 
ation of H&E stained sections of KGILtreated 
wounds (D) showed a thickened epidermis with 
orthokmtotic  maturation,  compared  with con- 
trol wounds (C). Trichrome  staining further 
totaled more  emensive  colhgea  deposition  be- 
neath KGF-treated wounds (arrows. F) com- 
pared with control wounds (E). (A-D)  x95; 
(E and F)  x 24. 
the nine individual pairs of mirror image wounds from the 
first animal are shown in Fig. 2. Whereas four of nine KGF- 
treated wounds were completely covered by epidermis (mean 
percent reepithelialization, 78.9  +  24.2%, n  =  9), none of 
the control wounds were 100%  reepithelialized (mean per- 
cent reepithelialization, 41.4  _+  12.7%,  n  =  9) (Fig.  2 A). 
Paired comparison of  each mirror image set of  wounds (shown 
as lines connecting each pair) revealed that in every case, KGF 
treatment  accelerated epithelialization  compared  with  its 
mirror image wound site. Besides a greater degree of  epithdiali- 
zation in KGF-treated wounds, paired analysis of epidermal 
thickness revealed  significantly thicker epidermis in KGF- 
treated wounds compared with mirror image control sites 
(p  <0.oo01)  (Fig.  2 B). 
Examination of all the wounds (n =  26 for the two animals) 
for epidermal maturity showed that only 4  of 26 wounds 
exhibited focal areas in which a well-developed granular layer 
was apparent. Of these four wounds, all were KGF-treated 
sites. 
Effects of  KGF on the Healing of  Full-thickness Wounds.  The 
effects of KGF on the healing of full-thickness wounds was 
evaluated in 31 pairs of mirror image wounds from nine sep- 
arate animals (Table 2). Wounds were initially evaluated four 
wk after the first application of KGF. KGF treatment consis- 
tently induced significant epidermal thickening compared with 
mirror image control sites  (0.18  +  0.12  and 0.31  +  0.22 
ram, epidermal thickness for control and KGF-treated sites, 
respectively; p  <0.0001).  Moreover,  the epidermis  in  the 
majority (77%) of  KGF-treated wounds possessed an epid~gi-iiis 
that exhibited pronounced, deep rete ridges, such as those 
seen in psoriasis (Fig.  1 D). This epidermal morphology was 
unusual, since healing of  full-thickness skin wounds is generally 
associated with a more flattened fete ridge pattern compared 
with normal skin (Fig.  1 C) (40).  Indeed, all of the control 
wounds examined in the present study (n  =  31) had a flat- 
tened epidermis with few, if any rete ridges evident (Table 
2, Fig. 1 C). KGF-treated wounds exhibited approximately 
six times as many fete ridges over the wound site compared 
with control wounds.  Whereas the epidermis from KGF- 
treated wounds was acanthotic in appearance, keratinocyte 
maturation was orthokeratotic and few mitoses were apparent 
(Fig.  1 D). When similar wounds on the same animal were 
treated with either EGF or bFGF, neither uniform epidermal 
acanthosis nor fete elongation was observed (data not shown). 
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Figure 2.  The effects  of KGF on the healing  of partial-thickness  wounds. 
Nine mirror  image  pairs of superficial  partial  thickness  wounds  were  created 
in the back of  a swine. Biopsies  were  obtained  from  both control  and KGF 
treated wounds  3 d after surgery. The percent epithelialization  over the 
wound (.4) and epidermal  thickness  of the healed  skin (B) were  measured. 
(Each line represents the values for one mirror image wound pair.) KGF 
accelerated the rate of healing  of partial-thickness  wounds; the mean per- 
cent epithelialization •  SD -  41.1 •  12.9  and 78.9 •  24.2% for control 
and KGF-treated  wounds, respectively  (A, arrows;  p <0.0002). KGF also 
induced significant  thickening  of the healed  epidermis  in partial thickness 
wounds (/3). Mean epidermal thickness  (ram)  •  SD -  0.06 •  0.02 and 
0.08 •  0.02 for control  and KGF-treated  wounds,  respectively  ~ <0.0001). 
Control, EGF or bFGF-treated wounds were similar in histo- 
logic appearance  to previously published studies (11, 21). 
In addition to its effects on the epidermis, KGF exposure 
was associated  with interesting effects on the regenerating 
dermis of the wound bed. Cellular elements in the granula- 
tion tissue of control or KGF-treated wound sites appeared 
similar,  with  fibroblasts  and immature vascular  elements 
present (Fig.  1, E  and F). However, there was a detectable 
difference in  the  ECM  of KGF-treated wounds.  Masson 
Trichrome staining revealed more mature collagen fibers in 
the superficial dennis of KGF-treated wounds (Fig. 1 F, arrows) 
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Figure  3.  The rate of wound contraction  of control and KGF-treated 
wounds. The size of control and KGF-treated  wounds was quantitated 
using computerized  image analysis. Each data point represents the mean 
+ SD of 16 wounds from four separate animals. No difference  was ob- 
served in wound  size  contraction  between  control  and KGF-treated  wound 
sites. 
compared with control wounds which showed relatively less 
abundant collagen (Fig.  1 E). 
It is possible  that the prominent rete ridges observed  in 
most KGF-treated wounds might be attributable to differ- 
ences in wound contraction. Computerized morphometric 
image analysis was therefore performed on both control and 
KGF-treated wounds at weekly intervals during the 4 wk 
after application of KGF (Fig.  3).  The rates  of contraction 
of control and KGF-treated wounds were indistinguishable, 
suggesting that differences in wound contraction could not 
account for the deep fete ridges of  most KGF-treated wounds. 
The basement membrane zone (BMZ)-associated surface 
of basal keratinocytes from control healing wounds, or un- 
wounded skin immediately adjacent to the wound sites ex- 
hibited cuboidal to flattened basal cells without obvious set- 
ration (Fig. 4, C and D). This was sharply contrasted with 
the epidermal basal layer of KGF-treated sites that exhibited 
numerous focal areas in which basal keratinocytes were elon- 
gated with a highly serrated basal surface, exhibiting deep 
processes that extended into the dermis (Fig.  4, A  and B). 
We also investigated whether KGF treatment was associated 
with alterations in the BMZ structure of the healing wound. 
Immunochemical localization of laminin within the BMZ 
revealed that despite the obvious difference in serrated basal 
cells, both KGF-treated (Fig.  5 B) and control (Fig.  5 A) 
wounds expressed a continuous layer of laminin suggesting 
that all or part of the BMZ had reformed in these wounds. 
In an effort to better define the apparent differences be- 
tween KGF and control wounds, EM was undertaken (Figs. 
6-8). Ultrastructural analysis of the epidermal basal layer from 
control and KGF-treated wounds revealed significant differ- 
ences. As expected (based upon light microscopic appearance), 
the surface of the basal keratinocyte in control wounds was 
flat with few extensions into the dermis (Fig. 6). Hemides- 
mosomes (Fig. 6, h) were apparent on the basement mem- 
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Epidermal thickness* 
(mm  _+  SD) 
Epidermal morphology 
(No.  wounds) 
PBS  KGF 
Expt.  Pairs  of wounds  PBS  KGF  Flat  Rete ridge  Flat  Rete  ridge 
1'  5  0.10  _+  0.04  0.15  _+  0.04  s  5 u  01  0  5 
2  5  0.16  _+  0.05  0.24  _+  0.1  5  0  3  2 
3  4  0.06  _+  0.02  0.13  _+  0.03  4  0  1  3 
4  2  0.15  _+  0.07  0.35  _+  0.07  2  0  0  2 
5  1  0.2  0.38  1  0  0  1 
6  2  0.17  _+  0.0  0.43  _+  0.07  2  0  1  1 
7  2  0.19  _+  0.03  0.29  _+  0.09  2  0  1  1 
8  4  0.35  _+  0.16  0.45  +  0.21  4  0  1  3 
9  6  0.31  _+  0.12  0.51  _+  0.36  6  0  1  5 
Total 9  31  0.18  _+  0.12  0.31  +  0.22  31  0  7  24 
* Epidermal thickness was measured by microscopy in vertical histologic sections as the distance (in millimeters) from the basal layer to the granular 
layer along the entire wound length. A minimum of 30 measurements was made for each histologic section. Where rete ridges were observed, mea- 
surements included the length along both the rete  ridges and in the intervening flatter epidermis. 
*Each experiment represents  results from one individual pig. 
SDifference between paired mirror image wounds (n  =  31 pairs for a total of 62 wounds) of KGF- and PBS-treated sites from nine different pigs; 
p  <0.0001. 
IIFlat refers to the appearance of the basal side of the epidermis and represents  an epidermis that essentially lacks rete  ridges. 
1Morphologic  appearance of the basal side of the epidermis exhibiting deep rete ridges. 
Figure 4.  The histologic  appearance of basal 
layer epidermal ceUs from two representative KGF- 
treated wounds (A and B) shows rete elongation 
and a  serrated basal  cell phenotype  with  long 
processes that extended into the dermis (arrowheads). 
By contrast,  the appearance of basal keratinocytes 
from normal skin adjacent to control wound sites 
(C) shows less rete elongation  and basal cells with 
nonserrated surfaces. Finally the epidermis from 
PBS-treated  wound  sites (D)  was  considerably 
flatter than that of either nonwounded or KGF- 
treated sites. Basal cells from control wound sites 
also had a smooth cell surface with few processes 
extending into the dermis,  x400. Figure S.  Immunolocalization  of  laminin 
(arrows)  in biopsies  (2 wk after surgery) from con- 
trol (,4) and KGF-treated  (B) porcine  wounds. Sec- 
tions were reacted with anti-laminin Abs using 
standard immunoperoxidase  techniques. A uniform 
layer of laminin (arrows)  deposition was observed 
within the BMZ of both control (A) and KGF- 
treated (B) wounds.  ￿  200. 
brane-associated,  lower surface of the cell, but only a few 
well-developed tonofilaments were observed. The papillary 
dermis  immediately below the keratinocyte was composed 
predominantly  of a  loose ECM  with  few collagen  fibrils 
present. 
In  comparison,  basal  keratinocytes  from  KGF-treated 
wounds showed striking differences (Figs. 7 and 8). The sur- 
face of the basal keratinocyte was often heavily serrated (Fig. 
7, arrowheads). The hemidesmosomes were better developed 
and thickened on the cytoplasmic side of the cell (Fig. 8, h). 
Thicker bundles of tonofilaments (Fig. 8, tf) were also abun- 
dant  within  the cytoplasm and in  some areas  the tonofila- 
ments were observed in conjunction with  the hemidesmo- 
somes.  Finally,  collagen fibrils were more readily apparent 
in the papillary dermis. The appearance of synthetically ac- 
tive dermal  fibrohlasts with  dilated endoplasmic reticulum 
(Fig. 8, er), suggests that collagen fibers in KGF wounds might 
result from in situ synthesis.  Well-formed anchoring  fibrils 
were not observed in KGF-treated or control wounds. How- 
ever,  collagen  fibers  in  KGF-treated  wounds  were  often 
oriented perpendicular to the BMZ and appeared to connect 
with the BMZ near hemidesmosomes. The organization  of 
collagen fibers adjacent to the BMZ suggests the possible ex- 
istence of a functional tonofilament-hemidesmosome-collagen 
fiber unit  or complex in  2-wk KGF-treated  wounds. 
Kinetic  Analysis of Rete Ridge Formation after KGF  Treat- 
ment.  In the initial series of experiments, biopsies were ob- 
tained on day 28 after wounding.  This day was chosen since 
it  corresponded  to a  time at  which  all  wounds  (KGF  and 
control) were healed and maximal contraction as assessed by 
computerized image analysis,  was observed (see Fig.  3). To 
examine whether the response to KGF was an early or late 
871  Staiano-Coico  et al. Figure 6.  Representative  electron  micrograph  of the dermal/epidermal  junction of a control wound (2 wk after surgery). The lower surface  of the 
basal keratinocyte  is relatively  flat with little interdigitation into the underlying tissue. Hemidesmosomes  (h) are apparent and the lamina densa (ld) 
is indicated. The granulation tissue is composed  primarily of loose ECM with few collagen fibers.  ￿  25,000. 
event after wounding, a kinetic analysis of the morphologic 
appearance of KGF- and vehicle-treated fuU-thickness wounds 
was performed at weekly intervals. 
At 7 d  after surgery, no significant closure was observed 
in control or KGF wounds, and crust covered the middle of 
the wounds (Fig. 9, A  and/3). Tongues of relatively undifferen- 
tiated epidermis, lacking a granular layer or stratum corneum, 
were observed at the wound edge (Fig. 9, A  and B). In con- 
trol wounds, the epidermis distal to the wound edge showed 
irregular acanthosis (Fig. 9 A, open arrow). In contrast, KGF- 
treated wounds already  showed evidence of more uniform 
deep rote ridge pattern at this time (Fig. 9 B, open arrow). 
Examination of the wound bed on day 7 revealed loose granu- 
lation tissue with concomitant inflammatory cell infiltrates 
in both KGF  and control wounds. 
By day 14 after wounding, both control and KGF-treated 
wounds were generally reepithelialized (Fig.  9,  C  and D). 
In controls, the epidermis covering the original wound area 
displayed typical features associated with acute wound healing, 
that is, the epidermis was flat, parakeratotic in areas, and weakly 
attached to the underlying granulation tissue (Fig. 9 C) (11, 
12).  By contrast,  the newly formed epidermis covering the 
KGF-treated wound sites already exhibited pronounced rote 
ridge  formation  consistent  with  better  attachment  of the 
epidermis to the underlying wound bed (Fig.  9 D).  As in 
control wounds, focal parakeratosis was observed in some KGF- 
treated wounds at this time. By 3 wk after wounding, com- 
plete differentiation of the epidermis was observed in both 
control (Fig. 9 E) and KGF-treated (Fig. 9 F) wounds. Again, 
KGF-treated wounds were thicker and more deeply interdigi- 
tared into the wound bed than the flattened epidermis of con- 
trol wounds. These results suggest that the KGF induces an 
alteration in epidermal morphology early during the wound 
healing process which persists for at least several weeks after 
wound dosure. 
Anal)sis of  I~liferation  R~onse in KGF-treated  Wounds.  The 
histologic appearance of KGF-treated  wounds superficially 
resembled the hyperproliferative epidermis seen in psoriasis 
and other dermatoses with psoriasiform hyperplasia (41). To 
determine whether, in fact, the epidermis from KGF-treated 
872  Keratinocyte  Growth Factor in Wound Healing Figure  7.  Representative electron miczograph of the dermal/epidermal  junction of a KGF-treated wound (2 wk after surgery). Basal keratinocytes 
from KGF-treated wounds exhibited serrations (arrowheads) that e~tended down into the underlying wound bed. Numerous collagen fibrils (c) were 
apparent in the papillary dermis of such  healed wounds,  x12,500. 
873  Staiano-Coico et al. Figure 8.  Representative electron 
micrograph (at higher magnification 
x 25,000)  of  the dermal/epidermal  junc- 
tion from a KGF-treated  wound (2 wk 
after surgery). The cell surface of the 
basal keratinocyte ~hibited  processes 
that interdigitated into the underlying 
dermis. Hemidesmosomes  (h) were  ap- 
parent and thicker than those  observed 
in control wounds (see Fig. 6). More- 
over, thicker and more abundant to- 
nofilaments (9  r) were  observed  in KGF- 
treated wounds. Dermal  fibroblasts  (fb) 
contained  abundant,  dilated  endo- 
plasmic reticulum (er) suggestive of a 
metabolically active state. 
wounds was hyperproliferative, a nuclear Ki-67-reactive Ab 
was used in frozen sections of full-thickness swine wounds 
(KGF and control)  during  the course of healing  (Fig.  10). 
Cell proliferation was assessed by Ki-67 reactivity which is 
present  only in actively proliferating  cells (39).  In  normal 
(unwounded) pig epidermis,  Ki-67 reactivity was localized 
focally within  the basal layer of the epidermis, with  "~9% 
of basal cells being Ki-67 + (Fig.  10 E; arrows). Within  1 wk 
after  wounding,  an  increase  in  the  prevalence  of Ki-67 + 
epidermal cells was observed in both control (Fig. 10 A, arrows) 
and KGF-treated (Fig. 10 B, arrows)  wounds. The magnitude 
of the proliferative response was, in general, greater in KGF- 
treated wounds (Fig. 10 B) compared with controls (Fig. 10 
A). As described above, by 2 wk after wounding, the majority 
of KGF-treated wounds exhibited deep fete ridges (see Fig. 
1). Examination of Ki-67 reactivity at this time showed that 
874  Keratinocyte  Growth Factor in Wound Healing Figure  9. Kinetic examination of the healing 
of full thickness wounds in response to KGE 
Control (A, C, and E) or KGF-treated (B, D, 
and F) wounds were biopsied day 7 (A and B), 
14 (C and D) or 21  (E and F) after surgery 
and their morphologic appearance assessed after 
H&E  staining.  At  1  wk  after  treatment, 
tongues of epidermis could be seen migrating 
over the wound beds (arrows indicate wound 
bed boundary). Whereas irregular acanthosis 
was observed at the edges of control wounds 
(A), a more uniform fete ridge pattern was ob- 
served in KGF-treated (B) wounds. By 14 d, 
both control (C) and KGF-treated (D) wounds 
had reepithelialized, although maturation of the 
epidermis was incomplete. The epidermis of 
control (C) wounds was  flat with relatively 
poor attachment to the underlying wound bed 
(c shows  a  deft between the epidermis and 
dermis). Equivalent  KGF-treated wounds (D) 
exhibited deep rete ridges. By 21 d, orthokera- 
totic maturation was observed in both control 
(E)  and  KGF-treated  (F)  wounds.  The 
epidermis from control (E) wounds remained 
flat and relatively thin, whereas the epidermis 
from KGF-treated (F) wounds retained its deep 
fete ridge appearance,  x100. 
Figure  10.  Assessment  of proliferative ac- 
tivity by Ki-67 reactivity in unwounded por- 
cine epidermis (E), healing epidermis from con- 
trol (A and C) and KGF-treated (B and D) 
wounds. Normal unwounded porcine epidermis 
(E) showed focal areas of nuclear reactivity  with 
Ki-67 within the basal layer of the epidermis. 
At 7 d after wounding, an increase in Ki-67 
reactivity  was observed in both control (A) and 
KGF-treated (B) wounds at the migrating edges 
of the epidermis. By 2 wk, Ki-67 reactivity  de- 
creased in both control (C) and KGF-treated 
(D)  wounds.  Whereas  2  wk  KGF-treated 
wounds  exhibited a  deep fete ridge pattern 
within the epidermis, the proliferative  activity 
of such wounds could be dearly distinguished 
from  that  of psoriasis  (F) which  showed  a 
similar morphologic appearance of the epider- 
mis, but displayed siguificantly increased Ki- 
67 reactivity, not only within the basal layer 
of the epidermis, but also within suprabasal 
layers.  (Thus  the  epidermis of KGF-treated 
wounds is not associated with persistent hyper- 
plasia as seen in psoriasis.)  x100. the number Ki-67 § cells decreased in both control (Fig.  10 
C) and KGF-treated (Fig. 10 D) sites relative to 1-wk wounds. 
Comparison of the epidermis from a 2-wk-old KGF-treated 
wound site (Fig.  10 D) and an active psoriatic lesion (Fig. 
10 F) showed distinctly different patterns of Ki-67 reactivity. 
Characteristically, psoriatic epidermis was thickened with deep 
rete ridges (Fig. 10 F). The epidermis was parakeratotic  and 
expressed  high numbers of Ki-67 + cells  (•47%)  within 
basal layer. Moreover,  Ki-67 reactivity was not confined to 
the basal layer, but was apparent in suprabasal cell layers as 
well (Fig.  10 F; arrows); -v27% of cells one layer above the 
basal layer were reactive with Ki-67. In contrast, in epidermis 
from the KGF-treated site, Ki-67 reactivity was much less 
abundant and was confined to the single basal layer ('~12% 
Ki-67 + cells within the basal layer). These data suggest that 
KGF induces a transient early proliferative  response with a 
persistent effect on epidermal morphology in the absence of 
sustained hyperplasia. 
Discussion 
The results of the present study indicate that KGF has 
marked effects on the epithelialization and healing of partial- 
and  fuU-thickness  porcine  wounds.  Although KGF  is  a 
member of the FGF family,  it interacts with an epithelial 
cell-specific  receptor (34). The restricted expression of the 
KGF receptor presumably would limit the direct effect of 
KGF to epithdial tissues, unlike that of related family members 
aFGF or bFGF, which are mitogenic for fibroblasts, endothelial 
cells, and epithelial cells (23,  24,  42). 
In the present experiments, KGF, as predicted, induced its 
predominant effects on the newly-formed epidermis. Epidermis 
from KGF-treated  wounds was  significantly  thicker than 
epidermis from mirror image controls. In addition, 77% of 
KGF-treated full-thickness wounds exhibited deep fete ridges 
that extended into the dermis. The ultrastructural features 
of the epidermis revealed a more mature basal keratinocyte 
with an undulating cell surface and better developed tonofila- 
ments and hemidesmosomes. Epidermal thickening similar 
to that exhibited by most healed KGF-treated full-thickness 
wounds, is also observed in human skin associated with psori- 
asis and some inflammatory dermatoses. However, the histo- 
logic appearance of KGF-treated wounds could be readily dis- 
tinguished from these disorders  by the normal pattern of 
orthokeratotic epidermal maturation, the presence of a granular 
layer, as well as by the absence of acute/chronic immune infiltra- 
tion into affected  tissue (above  that  of control wounds). 
Moreover, the Ki-67 staining revealed a proliferative pattern 
confined to the basal epidermal layer. This is distinctly different 
from psoriasis in which the basal layer and several suprabasal 
layers react intensely with Ki-67. Exogenous KGF, added early 
in wound repair appears to induce a transient proliferative 
response in keratinocytes that contrasts with the sustained 
epidermal hyperplasia  in psoriasis. 
The response of the epidermis to exogenous KGF is also 
different from that observed in response to either EGF or 
TGF-ot.  EGF,  TGF-ot,  and related  ligands have also been 
shown to directly affect wound reepithelialization (26, 28). 
When injected intradermally, EGF produces marked thick- 
ening of associated epidermis, but does not cause fete elon- 
gation. In experimental wounds, EGF and TGF-ot accelerate 
reepithelialization, but have minimal effects on overall epi- 
dermal structure. In skin wounds of transgenic mice that over- 
express TGF-c~ in the adult epidermis, exophytic growths occur 
which resemble papillomas on histologic examination (43). 
KGF-treated wounds were macular or slightly depressed upon 
healing, and the epidermis was clearly different from that 
of the papillomatous epidemlal hyperplasia in TGF-c~ trans- 
genic mice (43). The difference in the histologic appearance 
of EGF- and KGF-treated wounds is consistent with observed 
differences  in the ability of these molecules to  modulate 
epidermal differentiation, even  though both cytokines are mito- 
genic for keratinocytes (35). 
Also of interest was the apparent effect of KGF on the 
formation of granulation tissue within full-thickness wounds. 
KGF induced an increased appearance of more mature col- 
lagen fibrils within the superficial dermis. Whereas this ap- 
parent change in collagen appearance could have resulted from 
local alterations in wound contraction, ultrastructural anal- 
ysis suggests that the collagen apparent in the papillary dermis 
of KGF-treated wounds arises, at least in part, by de novo 
release of collagen from fibroblasts  within the granulation 
tissue (Figs. 6 and 7). Since KGF seems to be epithelial specific 
in its action, the stimulation of collagen within the fibro- 
blast would presumably occur via a secondary cytokine, per- 
haps released by the healing epidermis into the wound bed. 
Moreover,  the effects of KGF on collagen bundle formation 
are dearly distinct from those produced by treatment of full- 
thickness wounds by TGF-~ which stimulates collagen depo- 
sition more uniformly throughout the wound (25). 
The appearance of serrated basal layer epidermal cells (as 
assessed by light and electron microscopy) in conjunction with 
more mature collagen in the papillary dermis of KGF-treated 
wounds has significant implications for the strength and dura- 
bility of such healed wounds. The presence of serrated and 
nonserrated basal cells has been documented since the 1950s, 
but initially their function was unknown (44). More recent 
studies of Lavker and Sun (45) have suggested that the ser- 
rated basal cells are a primary anchoring force for binding 
of the epidermis to the dermis (45). The presence of greater 
numbers of serrated basal ceils within KGF-treated wounds 
compared with control wounds suggests that KGF might 
mediate better attachment of epidermis to the derails, thereby 
providing an increased resistance to shear forces that can cause 
retraumatization of newly healed wounds. KGF might be 
a useful therapeutic agent in the treatment of some wounds 
associated with blistering (such as epidermolysis bullosa) which 
exhibit poor epidermal-dermal cohesion. The action of KGF 
appears to be unique in this regard compared with other es- 
tablished growth factors such as EGF or bFGF which induce 
an epidermal morphology in healing wounds that is similar 
to the PBS-treated  control wounds presented in this study. 
These results strongly suggest that KGF not only affects ul- 
trastructural features of basal keratinocyte differentiation, but 
876  Keratinocyte  Growth Factor in Wound Healing also modulates (perhaps via induction of secondary cytokines 
originating  in the epidermis)  the maturity and phenotype 
of the underlying wound bed. Thus KGF may exert impor- 
tant effects on epidermal/dermal structure in its normal func- 
tions  as a paracrine  cytokine. 
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